Gwen Melincoff, Director at Protalix, holds 7.50K shares in Protalix (Ticker: PLX), holds ― shares in Gain Therapeutics (Ticker: GANX), holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA).
Gwen Melincoff latest transaction was an Uninformative Buy of ―.
What was Gwen Melincoff's most profitable transaction?
Gwen Melincoff’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gwen Melincoff's role in Protalix?
Gwen Melincoff's role in Protalix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.